Dengue Vaccine Impact on Diagnostic Testing

Diagnostic Considerations

The Centers for Disease Control and Prevention recommends nucleic acid amplification tests (NAATs) as the gold standard for acute dengue diagnosis in vaccinated populations, as they are not impacted by vaccination status 4
NS1 antigen detection is not significantly affected by prior vaccination and remains reliable for diagnosing acute dengue infection in vaccinated individuals during the first 7-10 days of illness 2
The World Health Organization implies that cross-reactivity with vaccine-induced antibodies makes it impossible to distinguish vaccine response from natural infection using standard IgM/IgG assays alone, with a specificity of 85.1% in vaccinated populations 1

For acute illness (≤7 days after symptom onset), prioritize NS1 antigen testing or PCR/NAAT as first-line diagnostics, as these are not affected by vaccination, according to the CDC 4, 3
If IgM/IgG testing is positive, confirmatory plaque reduction neutralization testing (PRNT) is essential to distinguish vaccine response from natural infection, with a PRNT titer ≥10 for dengue confirming recent natural dengue infection 4, 1